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Abstract
Background: In the field of translational neuroscience research, it is critical to utilize a large animal model to test the feasibility, safety, and functionality of novel
therapies. Here, we describe a protocol for the development of a large animal model of tremor.
Methods: In a pig model, tremor was induced with harmaline and measured with wireless accelerometers attached to the limbs. Three different doses of harmaline
were tested and three repetitive injections were made at 72-hour intervals. To fully characterize the drug-induced tremor, onset time, tremor amplitude, maintained
duration, and peak tremor frequency were analyzed.
Results: Harmaline-induced tremor appeared immediately following intravenous injection of harmaline. Tremor was maintained over 2 hours. Its frequency was
10–16 Hz, which was independent of doses. Dose-dependent responses were observed in tremor amplitude, triggering time, and tremor-maintained duration.
Repetitive injection of harmaline desensitized the harmaline effect.
Discussion: We provide a detailed protocol for training, drug injection, device selection, and tremor recording optimized to create a swine model of tremor with
harmaline. Our protocol provides reliable tremor in pigs and suggests pig as a valid translational large animal model of tremor.
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Introduction
Pigs have been broadly and increasingly used as a large animal
model in the biomedical and translational research fields due to the
similarity of their internal organ anatomy and biochemical physiology
to humans. Recently, pigs have also increasingly been used in the neuro-
science and biobehavioral research fields because pigs have a com-
patible size and volume of the brain to non-human primates; and
the anatomy and neurodevelopment of the pig brain is similar to the
human brain. The swine brain thus can accommodate multimodality
imaging and the surgical installation of multiple electrodes, similar
to that used for humans.1 Multiple neurologic models have been
developed and tested including Parkinson’s disease,2 traumatic brain
injury,3 and stroke.4 However, the essential tremor (ET) model has not
yet been fully examined in pigs or other large animal models.
ET is the most frequent form of pathologic tremor and one of the
most common adult-onset neurologic impairments.5 The incidence
rate for people age 60 and older is estimated at 6.3–9%.6 It affects
approximately 10 million people in the United States.5 Despite its high
prevalence and disabling effects, pharmacological intervention only
helps about 50% of patients with ET; and nearly one out of three
patients stops taking their medications.5 The development of new
therapies has been hampered by a lack of knowledge about tremor
pathophysiology and the lack of a validated preclinical model for
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evaluating potential tremor-suppressing drugs. Therefore, it is impor-
tant and necessary to develop an animal model of ET to investigate
underlying mechanisms and pathophysiology of ET and screen novel
drugs and other therapeutic options.
Harmaline, a b-carboline derivative, is widely used for experimental
analysis of tremor; and a rodent model of harmaline-induced tremor
has been used as a model of ET.7 In the rodent tremor model, the
tremor frequency and responsiveness to propranolol, ethanol, and
octanol are similar to that of humans with ET.7–9 Harmaline induction
of a fine, generalized 8–12 Hz tremor has also been demonstrated in
sheep and non-human primates.10,11 However, harmaline-induced
tremor has not been tested in pigs.
One reason why the harmaline-induced tremor model is regarded as
the best model of ET is that the olivocerebellar system plays a key role
in pathophysiological mechanisms underlying both harmaline-induced
tremor in animals7,9 and ET in humans.12 Thus, harmaline-induced
tremor in animal models may share underlying mechanisms relevant
to the understanding of tremor generation in human ET.12 For this
reason, a rodent harmaline-induced tremor model was developed and
used to investigate tremor pathophysiology. However, considering the
substantial anatomical differences between the rodent and human
brain, rodent models have limitations.9 The pig brain is gyrencephalic
and more closely resembles the human brain in anatomy and develop-
ment compared to the rodent brain.1 Therefore, here, we describe a
protocol for development and characterization of a harmaline-induced
tremor in the large animal pig model.
Methods
Animals
Yucatan mini-pigs (two) and domestic pigs (five) were used. Animals
were socially housed in pairs and maintained in accordance with the
Guide for the Care and Use of Laboratory Animals in an Association
for Assessment and Accreditation of Laboratory Animal Care Inter-
national (AAALAC), international-accredited facility. Swine cages
were cleaned daily and sanitized weekly before feeding. The animals
were fed standard chow (Purina Animal Nutrition, LLC, Shoreview, MN)
as recommended by the attending veterinarian and provided
ad libitum access to tap water. For completeness, enrichment was
provided in the form of twice weekly rotation of toys and daily treats.
Records of cleaning schedules as well as temperature and humidity
recordings were monitored daily. Each animal was checked daily
by the animal care staff and 3 days per week by the Mayo Clinic
veterinarians. All experiments were approved by the Mayo Clinic
Institutional Animal Care and Use Committee.
Acclimation to tremor-monitoring procedures
Pigs are intelligent animals that sensitively respond to external
stimuli and are relatively easy to train. Before the harmaline injection,
animals were acclimated to the tremor-monitoring room, experimental
condition, the accelerometer attachment on the limb, and experimenter
(Figure 1A). A small empty space (,10 ft 6 ,15 ft) was dedicated for
tremor monitoring using fences to limit the space. For the acclimation
Figure 1. Harmaline-induced Tremor Model in Pig. (A) Diagram of experimental design. Animals were acclimated to the accelerometer attachment and
experimental environment before the recording session. Harmaline was repetitively injected three times at 2-day intervals. During the recording session, baseline
(for 30 min) was recorded first and harmaline was injected through the intravenous (IV) line in the ear. (B) Photo of device attachment. Accelerometers and the IV
line were attached and maintained throughout the recording session. (C) Raw tremor traces. Tremors were detected through the accelerometer attached on the
limb. Rhythmic motion was significantly increased by harmaline injection (6 mg/kg). (D) Harmaline-induced tremor frequency. The predominant tremor frequency
induced by harmaline is 10–16 Hz in pig. There is another significant tremor detected at 8–10 Hz.
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to the recording environment and tremor-monitoring procedure,
animals were guided to voluntarily walk to the monitoring room, and
two empty containers of accelerometers with a weight matched to the
actual device (15.6 g in Figure 1B, inset) were attached to the limbs
(Figure 1B). The accelerometer was attached while the animal was
distracted by a treat and water. The accelerometer was placed onto the
limb and then wrapped with an elastic vetband (VetOne, Escondido,
CA) around the limb. Once the accelerometer was attached to the
limb, animals were allowed to freely move around for 15–30 minutes.
This acclimation procedure was performed prior to feeding twice a
day, up to 5–7 days. While the pig was in the monitoring room, the pig
was provided treats, water, and regular chow. After the acclimation
procedure, the animal was walked back to its home cage. Once it
completed the procedure, it received a fruit snack and regular chow as
a reward.
Harmaline-induced tremor
Once the animal was acclimated to the accelerometer, harmaline-
induced tremor monitoring was performed. On the day of the experi-
ment, the pig was temporarily sedated with a combination of
ketamine (10 mg/kg) and medetomidine (0.2 mg/kg) intramuscularly.
A venous indwelling catheter was inserted into an ear vein and
the accelerometer was attached to its limbs (Figure 1B). Before the
accelerometer was attached, the skin was cleaned with water and hairs
were shaved with a clipper. Then, the skin was covered with ioban
drapes (MMM, St. Paul, MN). The accelerometer was attached
on top of the ioban drape-covered area using a dressing band-
age and was wrapped with an elastic vetband (Figure 1B). Once all
equipment was attached, the pig was awakened by atipamezole
administration (1 mg/kg intravenously). The animal would typically
regain consciousness and stand within 5–10 minutes. However,
we waited for approximately 60 minutes to allow the animal to
fully recover from the anesthesia and ambulate normally. Once the
animal could walk normally and maintain balance (as determined
by the ability to respond quickly to a mild push), a baseline walk was
monitored with the attached accelerometer for 30 minutes. Then,
harmaline was administered intravenously at a dose of 2.5, 5, and
6 mg/kg dissolved in sterile saline (10 mL). Harmaline (harmaline
hydrochloride, Sigma-Aldrich, St. Louis, MO) is a yellow powder
and saline with harmaline is yellow. Owing to its color, we could
easily visualize the harmaline solution in the intravenous (IV) line
and determine the injection time. We freshly prepared harma-
line solution immediately before the injection. Because the fully
awake animal was responding to the saline injection through the
venous indwelling catheter in the ear, extra caution was required.
Once the prepared harmaline saline was injected, the IV line was
cleared with saline (saline flush) to deliver the full dose of harmaline
to the animal. Accelerometer monitoring was performed for a
maximum of 3 hours. Harmaline-induced tremor monitoring was
repeated up to three times at 72-hour intervals. A timeline of the
experiment is shown in Figure 1A.
Wireless movement sensor
To perform consistent and reliable measurement of tremor
over time, we built a band-type inertial measurement unit (IMU),
which consisted of an MSP430 microcontroller (MSP430F1611, Texas
Instruments, San Diego, CA) and low-cost inertial sensors of a three-axis
accelerometer and magnetometer (LSM303DLM, STMicroelectronics,
Geneva, Switzerland). A rechargeable battery (PSE H503438-PCM
[3.7 V, 680 mAh], PSE, Jinan, China) was embedded and guaranteed
approximately 8 hours of operation. The IMU was designed to sense
¡8 g acceleration and the sampling rate was set at 100 samples/
second. Sensing-data parameters were preprocessed in the micro-
controller and transmitted via the embedded Bluetooth module
(Parani-ESD200, Sena Technologies Inc., Seoul, Korea) to a portable
computer. The data acquisition was controlled by a custom-made PC
program. For tremor detection and analysis, three-axis accelerations
(x [n], y [n], and z [n], where n is the sample) were used.
Tremor measurement
Motion activity was measured with an in-house fabricated wireless
movement sensor (Figure 1B, inset). Motion power was transmitted
wirelessly and recorded digitally. The device was calibrated by
dropping a 2.75-g ping-pong ball 5.7 cm and adjusting the amplifier
sensitivity so the recorded signal was 1 cm on an oscilloscope set at
1 V/cm. Data were sampled at 100 Hz, collected in 5-second bins, and
exported to MatLab 2016b (MathWorks, Natick, MA) (Figure 1C).
In MatLab, fast Fourier transform (FFT) was performed on amplitude
of accelerometer data in the time domain to obtain power spectra in
the frequency domain (Figure 1D). The total motion power for each
10-minute epoch was calculated between 0 and 10 Hz (non-tremor
motion spectrum) and between 10 and 16 Hz (the harmaline tremor
frequency bandwidth), and the motion power ratio (MPR) then was
calculated.
MPR 5 (10–16 Hz power)/(0–10 Hz power)
Each 10-minute epoch was divided into 5-second bins to calculate
MPR and each of these MPR calculations were normalized using the
averaged MPR of the 30 minute baseline (Figure 2A,B).
Tremor analysis
To fully characterize harmaline-induced tremor, tremor was analyzed
into four categories: 1) latency of tremor onset; 2) tremor amplitude;
3) maintained duration, which is the duration until the tremor is gone;
and 4) peak tremor frequency (Figure 2C). The data were divided into
1-second time frames and FFT performed to determine the MPR. To
find significant tremor frames, Gaussian fit was performed to the MPR
of each frame and frames that had a p-value less than 0.01 were
selected. We define the onset time as the time from the end of the IV
push and flush to the time at which tremor criteria was met as described
above. Tremor amplitude was measured as root-mean-square of
5-minute window where the maximum values were obtained between
60 and 90 minutes after harmaline injection. Maintained duration was
defined by the time between the first frame and the last frame of
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significant tremor detection. Using MPR, we characterized the tem-
poral profile of harmaline-induced tremor. A total of seven pigs were
used to optimize the procedures. Three concentrations of harmaline
(2.5, 5.0, and 6.0 mg/kg) were used to characterize the harmaline-
induced tremor profile (n 5 2, 2 and 3, respectively). Since harmaline
effect is attenuated by repetitive injections, consistent with previous
rodent data,13 harmaline (6.0 mg/kg) was injected three times, 72 hours
apart (n 5 3).
Results
Harmaline induced significant motion tremor in the pigs (Figure 1C).
Tremor was apparent both during laying and standing;14 however,
it was enhanced during movements such as standing and walking
(Figure 3).15 The amplitude of raw data before and after harmaline
injection is shown in Figure 1C. The tremor frequency was 10–16 Hz
(Figure 1D). The time course of mean MPR of the harmaline-induced
tremor is shown in Figure 2A,B. The overall averaged MPR of the
first harmaline injection was dose dependent (mean MPR, 1.34, 1.57
and 1.93; 2.5, 5, and 6 mg/kg of harmaline, respectively; p , 0.001 by
analysis of variance [ANOVA]) (Figure 2A). The harmaline-induced
tremor was robust; however, its amplitude and appearance was
irregular and both decreased and slowed in a nonlinear manner
throughout the whole experiment period. To characterize harmaline-
induced tremor, four parameters were analyzed: onset time, ampli-
tude, total tremor period, and the peak tremor frequency.
Harmaline initiated tremor in a concentration-dependent manner.
High concentration (6.0 mg/kg) harmaline induced the tremor almost
immediately after harmaline injection (0.4 min), whereas low con-
centration harmaline (2.5 mg/kg) had a delayed tremor onset time
(1.5 min) (Figure 2C, onset time of tremor). We also compared the total
duration of harmaline-induced tremor at the first round of harmaline
injection: tremor with 2.5 mg/kg was maintained for 125.2¡ 18.2 min;
with 5 mg/kg, 120.93¡ 28.2 min; and with 6 mg/kg, 172.6¡ 5.1 min
(Figure 2C, maintained duration). We separated and analyzed the
Figure 2. Dose Dependence and Desensitization to Harmaline Effect. (A) Dose dependency of harmaline effect. Motion power ratio (MPR) was calculated
by tremor with 10-minute epochs. The normalized MPR was obtained by dividing each MPR by the average of baseline MPR. Harmaline-induced tremor was
dependent on the concentration of harmaline. Three different concentrations of harmaline were tested in pigs. The low concentration of harmaline (2.5 mg/kg)
showed weaker MPR than the two higher concentrations (5.0 and 6.0 mg/kg) of harmaline. Light-grey dashed line indicates the point of harmaline injection.
The error bars represent the standard error of the mean. (B) Desensitization to harmaline effect. The harmaline effect (6 mg/kg) was reduced by repetitive injections
of harmaline. At the third injection, the onset-time of tremor induction was significantly delayed (70 minutes) and the maintained duration was decreased by
73.9 min (maintained only for 98.3 minutes). (C) Dose dependency of harmaline-induced tremor. Onset time of tremor, amplitude, maintained duration and
frequency profile were analyzed. *p,0.05, ***p,0.0001.
Figure 3. Comparison of Harmaline-induced Tremor Between Standing
and Lying. (A) Raw tremor traces. Rhythmic motion induced by harmaline
(6 mg/kg) was significantly larger while standing compared to lying down.
(B) Harmaline-induced tremor frequency. Power spectrum analysis was performed.
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amplitude of tremor: 1.08 ¡ 0.03, 1.25 ¡ 0.04, and 1.34 ¡ 0.04
seconds (mean ¡ standard error of the mean; 2.5, 5, and 6 mg/kg,
respectively), which is dose-dependent (Figure 2C, tremor amplitude;
2.5 mg/kg vs. 5 mg/kg, p , 0.0001; 2.5 mg/kg vs. 6 mg/kg,
p ,0.0001; 5 mg/kg vs. 6 mg/kg, p ,0.0001 by t-test). The peak
tremor frequency was also analyzed and it was consistent throughout
three different concentrations of harmaline (Figure 2C, Peak tremor
frequency; 13, 14, and 14 Hz with 2.5, 5, and 6 mg/kg).
In the previous study with rodents,13 the repeated administration
of harmaline showed a progressive loss of drug-induced tremor. There-
fore, we also examined the pattern of harmaline tolerance by repetitive
injection. To minimize tolerance, we performed harmaline injection at
48-hour intervals. There was a significant decline in mean MPR with
repeated injections. The mean MPR of total duration after harmaline
(6 mg/kg) administration from the first injection throughout the third
injection was 1.87, 1.38, and 1.18, respectively (Figure 2B; p , 0.001
by ANOVA).
Discussion
Here we demonstrated an experimental method to develop a
harmaline-induced tremor model in the pig. We used wireless accelero-
meters, which can also be used for humans (Figure 1B), and observed
postural and action tremors. MPR was calculated and used for analysis
and three doses of harmaline were tested. To fully characterize the
harmaline-induced tremor, onset time, amplitude, total tremor period,
and the peak frequency were identified, and these parameters
except frequency were affected in a concentration-dependent manner
(Figure 2A,C). In previous studies, repeated administration of harma-
line in rats led to the development of desensitization of tremorogenic
effects of harmaline.13 In pigs, repetitive harmaline injection reduced
the severity of harmaline-induced tremor, which coincides with pre-
vious studies (Figure 2B).7,8
Advantages of the large animal tremor model
ET and other tremor disorders have a tremendous impact on patients’
quality of life, and clearly warrant further study into the mechanisms
by which they arise and options for effective tremor suppressing
therapy. As noted in the introduction, both basic and preclinical
studies have previously employed a small animal model of harmaline-
induced tremor. While these models have provided some insight into
the pathophysiology and treatment of tremor,8 rodent models are
limited by the substantial anatomical differences between rodent
and human thalamic functions (e.g., the rodent thalamus lacks inter-
neurons).9,16 However, to advance further along the translational
research spectrum it is critical to have a model, such as the pig, that
more closely resembles the human brain in anatomy and development
compared to the rodent brain.1 Furthermore, given that the swine
brain is comparable in size and volume to the non-human primate
brain, it is large enough to accommodate multimodality imaging
and the surgical insertion of multiple electrodes. As a result, the swine
model can be used to investigate the mechanisms by which tremor
arises and to screen drugs and other potential therapeutic interventions
for efficacy.
Behavioral manifestations of harmaline-induced tremor
Since a large animal has been used in this study, several other
behavioral and physiological changes could be easily detected. Tremor
mostly started whole body and limbs and maintained at the limbs for
a long time (Video 1). For the first 30–60 min of harmaline infusion,
some animals displayed whole body trembling, agitation, barking and
falling, which were dependent upon the harmaline dosage. At this
stage (Video 1), the skin often turned to red due to hyperthermia.
One animal (out of seven) showed emesis with 6 mg/kg of harmaline at
the first injection; however, other pigs did not show this type of
reaction. Pigs are not in-bred species, and thus may demonstrate
greater individual variability.
Limitations of future directions
While this is a promising model for future studies, we acknowledge
some limitations of the present study. First, harmaline was infused
intravenously. Thus, it can affect central and peripheral nervous
systems as well as other systems in the body, which may cause direct
or indirect autonomic physiological changes. To isolate the central
nervous system-involved tremorgenesis, microinjection targeting a
specific brain area needs to be developed and tested. In addition, since
the infusion speed and circulation cannot be controlled experimentally
with this IV infusion method, these may confound the precision on our
measurements of onset time.
Second, in ET and other action tremors in humans, tremor is
measured while the posture of the human with tremor is well con-
trolled (e.g., sitting on a chair, or walking slowly). We observed that
tremor was more noticeable during standing and walking compared
to lying down (Figure 3 and Video 1). In the future, we also need to
consider standardization of the animal posture and activities, which
will allow for more specific quantification of action vs. rest components
of a harmaline-induced tremor.
Video 1. Harmaline-induced Tremor (6 mg/kg, i.v. injection).
(A) Before injection. (B) Lying after harmaline injection. (C) Walking 30 minutes
after harmaline injection. (D) Walking around 90 minutes after harmaline
injection.
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We observed a similar desensitization phenomenon to that described
in the rat model. In rats treated with harmaline, this effect has been
associated with extensive loss of Purkinje cells in parasagittal bands of
cerebellar cortex.9,17 Because this will limit the number of times an
individual animal could be used for drug or device testing, use of the
pig model is acknowledged to be resource intensive. However, it is also
possible that more extended rest periods than those employed in this
study may delay desensitization further.
We also noted an interesting bimodal response in the harmaline-
induced tremor amplitude in both the 5 mg/kg dose condition and in
the second injection of 6 mg/kg of harmaline. We could not generate a
definitive physiologic explanation for why this bimodal response may
occur. To determine the reliability of this finding and test hypotheses
for why it may occur, a larger sample size would be needed.
Finally, here we have tested and characterized the harmaline-
induced tremor in pigs. While it is important to note that the
harmaline-induced tremor model in the pig does not directly model
the underlying disease pathophysiology of ET, it potentially involves
some of the same underlying neural circuits.7,8,12 However, due to
its faithful reproduction of action tremor in a large animal model,
this model will be valuable in future research to better understand the
underlying neurophysiology contributing to ET and other action tremors,
as well as the mechanism by which different therapeutic interventions
ameliorate tremor. The harmaline-induced swine tremor model developed
here could become a platform for preclinical testing of new drugs and
novel devices for tremor and translational research and also could
become a more general tool for basic research.
Conclusion
We provide an experimental behavior protocol to develop a drug-
induced tremor model in a large animal, pig, and suggest this as
a valuable preclinical model to better understand the underlying
neurophysiology contributing to ET and other action tremors, as well
as the mechanism by which different therapeutic interventions amelio-
rate tremor.
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